Cargando…
Advanced Cellular Models for Preclinical Drug Testing: From 2D Cultures to Organ-on-a-Chip Technology
SIMPLE SUMMARY: Novel strategies that aim at personalizing cancer therapy are in rapid evolution. In the past decade, new methods to test for the efficacy of either standard-of-care medicines or novel targeted compounds have been implemented. In this review, we introduce the reader to experimental s...
Autores principales: | Foglizzo, Valentina, Cocco, Emiliano, Marchiò, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367322/ https://www.ncbi.nlm.nih.gov/pubmed/35954355 http://dx.doi.org/10.3390/cancers14153692 |
Ejemplares similares
-
Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy
por: Foglizzo, Valentina, et al.
Publicado: (2022) -
Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer
por: Foglizzo, Valentina, et al.
Publicado: (2021) -
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
por: Lim, Jungeun, et al.
Publicado: (2021) -
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
por: Fu, Jingyu, et al.
Publicado: (2023) -
The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology
por: Guo, Yuxi, et al.
Publicado: (2023)